Ruthenium red is a synthetic inorganic dye with a deep red color that has become one of the most versatile chemical tools in biology and pharmacology. It started out in the 1800s as a simple stain for plant tissues, but researchers eventually discovered it could block calcium from moving through specific channels in cell membranes, turning it into a widely used probe for studying everything from muscle contraction to pain signaling. That dual identity, part dye and part drug, makes it unusual among laboratory reagents and worth understanding on its own terms.
What Ruthenium Red Actually Is
At its core, ruthenium red is a cluster of three ruthenium metal ions bridged together and surrounded by ammonia molecules, chloride ions, hydroxyl groups, and water molecules. A crystal-structure analysis showed the composition to be a trinuclear complex in which each ruthenium ion sits at the center of an octahedral arrangement of ligands, with four ammonia molecules forming a square plane and either water or hydroxyl ions filling the remaining positions.1American Journal of Botany. Crystal‐Structure of Ruthenium Red and Stereochemistry of Its Pectic Stain The compound carries a strong positive charge, which is central to nearly everything it does: it sticks to negatively charged molecules in tissues, and it plugs into negatively charged pores in ion channels.
In solution, ruthenium red is a vivid cherry-red. It dissolves readily in water, and in practice researchers add it at concentrations ranging from nanomolar (for channel-blocking experiments) up to millimolar (for staining). That enormous range of working concentrations hints at the breadth of its applications.
A Stain for Plant Walls and Bacterial Coats
Botanists were the first to put ruthenium red to use, employing it as a stain for pectin, the gel-like polysaccharide that helps glue plant cell walls together. Pectin carries negative charges along its backbone, and ruthenium red’s strong positive charge lets it bind tightly and produce a visible color. Researchers studying seed coat development in the model plant Arabidopsis, for example, use ruthenium red staining to reveal whether mutant seeds produce normal amounts of mucilage pectin: wild-type seeds show intense, evenly spherical staining, while mutants with disrupted pectin synthesis show only patchy, irregular color.2PubMed Central. RHM2 Is Involved in Mucilage Pectin Synthesis and Is Required for the Development of the Seed Coat in Arabidopsis That kind of simple visual readout makes the dye invaluable in plant genetics, where identifying mutants that lack normal pectin is a routine screening step.
Over time, microbiologists adopted the same chemistry. Bacteria often surround themselves with a slimy layer called a glycocalyx, made of sugar-rich polymers that carry negative charges. Ruthenium red binds those polymers and makes the glycocalyx visible under the electron microscope, revealing a fibrous matrix that would otherwise collapse and vanish during sample preparation.3PubMed. Ruthenium red and the bacterial glycocalyx Before this technique was refined, scientists knew bacteria had outer coats but could not see their fine structure in any detail. Protocols for biofilm imaging now routinely include ruthenium red alongside fixatives like glutaraldehyde and osmium tetroxide to preserve and stain the extracellular polymers that hold biofilm communities together.4PubMed. Enhanced visualization of microbial biofilms by staining and environmental scanning electron microscopy
Blocking the Mitochondrial Calcium Uniporter
The discovery that transformed ruthenium red from a histological curiosity into a pharmacological tool came when researchers found it could prevent calcium from entering mitochondria. Mitochondria take up calcium through a channel called the mitochondrial calcium uniporter (MCU), and ruthenium red plugs that channel at very low concentrations.5PubMed Central. The mitochondrial calcium uniporter is a multimer that can include a dominant-negative pore-forming subunit This matters because calcium overload inside mitochondria is a key step in cell death during events like a stroke or heart attack. If you can block the uniporter, you can, at least in principle, reduce that damage.
In research on brain injury, for instance, ruthenium red has been used to block MCU in rat models of cognitive impairment triggered by metabolic stress. By reducing mitochondrial calcium accumulation in brain regions like the hippocampus and prefrontal cortex, the compound appeared to protect mitochondrial function and preserve bioenergetics.6PubMed. Ruthenium red, mitochondrial calcium uniporter inhibitor, attenuates cognitive deficits in STZ-ICV challenged experimental animals And broader reviews of ruthenium compounds in neurological disease have pointed to calcium-channel blockade as a mechanism for reducing tissue injury after cerebral ischemia-reperfusion, the kind of damage that occurs when blood flow to the brain is temporarily cut off and then restored.7The Journal of Pharmacology and Experimental Therapeutics. The Role of Ruthenium Compounds in Neurologic Diseases: A Minireview
Effects on TRP Channels and Pain Sensing
Ruthenium red does not limit itself to mitochondria. It is one of the best-known blockers of TRP channels, a large family of ion channels that sit in cell membranes and respond to stimuli like heat, cold, pressure, and certain chemicals. Among TRP channels, the TRPV subfamily (the “V” stands for vanilloid, after the compound in chili peppers) has received the most attention, and ruthenium red blocks TRPV pores broadly.8PubMed. Ruthenium red: Blocker or antagonist of TRPV channels? Structural studies have shown that ruthenium red physically lodges in the pore region of these channels, preventing ions from flowing through.9PubMed Central. Molecular details of ruthenium red pore block in TRPV channels
This TRP-blocking ability connects directly to pain research. TRPV1, the channel activated by capsaicin (the heat compound in chili peppers), sits on pain-sensing nerve endings. In isolated rabbit ear preparations, ruthenium red completely prevented the nerve response to capsaicin without affecting responses to other pain-inducing chemicals like bradykinin, suggesting it targets the capsaicin-specific activation pathway rather than shutting down nociceptors generally.10PubMed. Ruthenium red selectively prevents capsaicin-induced nociceptor stimulation
When delivered directly into the spinal cord of rats, ruthenium red produced dose-dependent pain relief against formalin-induced pain, and it blocked the behavioral pain response to capsaicin injected into the spinal space. It did not, however, block the effects of substance P (another pain-signaling molecule), pointing to a mechanism in which ruthenium red prevents the release of pain-related neuropeptides rather than blocking their receptors downstream.11PubMed. The analgesia induced by intrathecal injection of ruthenium red Mouse studies confirmed that ruthenium red injected locally into the skin or into the brain ventricles reduced pain responses in both capsaicin and formalin pain models.12PubMed. Ruthenium red and capsazepine antinociceptive effect in formalin and capsaicin models of pain in mice
These findings have made ruthenium red a staple in pain biology laboratories. It is not used as a painkiller in patients, but as a tool to dissect which channels and pathways are involved in different types of pain. If ruthenium red blocks a pain response, that tells the researcher a TRP channel or calcium-dependent mechanism is involved.
Ryanodine Receptors and Muscle Research
A third major target is the ryanodine receptor (RyR), a massive calcium-release channel found in the internal calcium stores of muscle cells. When a muscle cell needs to contract, ryanodine receptors open and flood the cell interior with calcium. Ruthenium red inhibits these receptors, and the way it does so is complex: it binds to multiple sites on both the cytoplasmic and the internal-store sides of the channel, can reduce the channel’s open probability dramatically, and at certain concentrations induces partial conductance states rather than a clean on-off block.13PubMed. Ruthenium red modifies the cardiac and skeletal muscle Ca(2+) release channels (ryanodine receptors) by multiple mechanisms
Single-channel recordings of skeletal muscle ryanodine receptors showed that submicromolar concentrations of ruthenium red applied from the cytoplasmic side produced a flickery, all-or-none block that was strongly voltage-dependent, with a Hill coefficient near 2, meaning more than one molecule of ruthenium red participates in plugging the pore.14PubMed Central. Block by ruthenium red of the ryanodine-activated calcium release channel of skeletal muscle In cardiac muscle cells, the same concentration range inhibited the ryanodine receptor’s open probability by roughly 20 to 50 times and cut the frequency of calcium sparks (tiny, localized bursts of calcium release) about tenfold.15Biophysical Journal. Mechanism of Ruthenium Red Inhibition of Ryanodine Receptor Channels and Ca2+ Sparks in Cardiac Muscle
By shutting down ryanodine receptors, ruthenium red lets researchers separate mitochondrial calcium uptake from the broader calcium cycling in muscle. If you block the ryanodine receptor and calcium sparks disappear, you know those sparks depended on calcium released from internal stores rather than calcium entering from outside the cell. That logic has been central to cardiac physiology work exploring how mitochondria synchronize their energy production with the heartbeat. In adult rabbit heart cells, ruthenium red blocked the mitochondrial calcium transients that accompany each contraction without eliminating the cytoplasmic calcium transient, confirming that the uniporter mediates beat-to-beat mitochondrial calcium uptake and may help match energy supply to demand.16Biophysical Journal. Ruthenium Red-Sensitive Mitochondrial Ca2+ Uptake Mediates Mitochondrial Ca2+ Transients during Contraction in Adult Rabbit Cardiac Myocytes
The Purity Problem
One of the most persistent headaches with ruthenium red is that commercial preparations are rarely pure. What you buy labeled “ruthenium red” is actually a mixture of the trinuclear compound and several related ruthenium complexes. This matters more than you might think, because the contaminants can be biologically active, sometimes more so than ruthenium red itself.
A careful comparison of crude and purified ruthenium red preparations found that the crude material was about 7 to 10 times more potent at inhibiting the mitochondrial calcium uniporter than highly purified ruthenium red, on an equal-concentration basis.17PubMed. Inhibition of the mitochondrial Ca2+ uniporter by pure and impure ruthenium red The same relative potency held for both the forward and reverse modes of calcium transport through the uniporter, and the authors concluded that the active inhibitor might not be ruthenium red itself, but one or more of the other ruthenium complexes present as contaminants. This finding cast a long shadow over decades of earlier work that had assumed the effects of “ruthenium red” were attributable to the named compound.
Researchers working with intact cells face additional complications. In isolated rat heart cells, concentrations of ruthenium red up to about 1 micromolar reduced mitochondrial calcium uptake, but this turned out to be a secondary effect caused by a drop in total intracellular calcium, because ruthenium red was also inhibiting cell contraction. Higher concentrations (around 5 micromolar) shut down contraction entirely, and still higher concentrations (10 to 25 micromolar) triggered spontaneous calcium oscillations and contractile waves.18PubMed. Use of ruthenium red as an inhibitor of mitochondrial Ca(2+) uptake in single rat cardiomyocytes The authors of that study cautioned that any effects in intact cells should not be automatically interpreted as direct mitochondrial uniporter inhibition. In short, ruthenium red hits so many targets at once that untangling its effects in a living cell requires careful controls.
Ru360 and the Search for Selectivity
The purity and selectivity problems with ruthenium red motivated the development of Ru360, a simpler, oxygen-bridged dinuclear ruthenium amine complex. Ru360 was designed to target the mitochondrial calcium uniporter specifically, and it delivers. In isolated heart mitochondria, Ru360 inhibited calcium uptake with a half-inhibitory concentration of about 0.18 nanomolar, compared to roughly 6.85 nanomolar for ruthenium red, making it around 40 times more potent.19Journal of Biological Chemistry. Oxygen-bridged Dinuclear Ruthenium Amine Complex Specifically Inhibits Ca2+ Uptake into Mitochondria in Vitro and in Situ in Single Cardiac Myocytes Crucially, Ru360 does not block ryanodine receptors or TRP channels at the concentrations used for uniporter inhibition, so results obtained with Ru360 can be more confidently attributed to mitochondrial calcium uptake.
Ru360 has not replaced ruthenium red entirely, though. Ruthenium red remains useful precisely because of its broad target profile: if you want to shut down multiple calcium pathways at once to see whether any of them matter for a given process, ruthenium red is the blunt instrument of choice. Ru360 is the scalpel you reach for when you need to isolate the mitochondrial component. Many labs keep both on hand.
Neurotoxicity and Safety Limits
Ruthenium red is not a benign bystander in the tissues it touches. Studies in primary cell cultures showed that the compound enters the cell bodies of neurons and causes visible damage: vacuoles form inside the soma, and neurites (the thin extensions neurons use to communicate) fragment and break apart. Astrocytes, the support cells of the brain, did not take up the dye and showed no signs of damage under the same conditions. The selective neurotoxicity appears to be tied to the ability of neurons, but not astrocytes, to internalize the compound.20PubMed. Selective neurotoxicity of ruthenium red in primary cultures
This neurotoxic potential has been documented both in cell cultures and in whole-animal experiments, and it is described as including neurodegeneration.21Journal of Neuroscience Research. Ruthenium red neurotoxicity and interaction with gangliosides in primary cortical cultures For this reason, ruthenium red is not a candidate for systemic drug use in humans. Its value is as a laboratory reagent: applied to isolated cells, tissue slices, or injected in tiny amounts into specific sites in animal models. Even in those contexts, researchers must account for the possibility that any behavioral or physiological changes they observe reflect toxicity rather than clean pharmacological blockade.
Why Researchers Keep Using It
Given its messiness, lack of selectivity, impurity issues, and neurotoxicity, you might wonder why ruthenium red persists as a laboratory staple rather than being replaced by cleaner tools. The answer is partly historical momentum: decades of published data reference it, so new studies that use the same reagent can be directly compared to older work. But there is a more practical reason. No single replacement covers all the ground that ruthenium red does. If you want to block TRP channels, there are selective antagonists for individual subtypes, but none that broadly hits the whole family the way ruthenium red does. If you want to block the mitochondrial uniporter, Ru360 works beautifully, but it will not also reveal whether ryanodine receptors are involved in your system. And if you want to stain negatively charged polymers for electron microscopy, ruthenium red remains the go-to reagent with no serious competitor for that application.
The compound’s promiscuity, in other words, is both its weakness and its strength. A clean experiment often starts by throwing ruthenium red at a system to see what happens, then follows up with selective agents to narrow down which specific channel or target was responsible. That two-step logic, broad inhibitor first then selective inhibitor second, is a standard approach in pharmacology, and ruthenium red fills the “broad inhibitor” role for calcium-dependent processes as well as anything available.
Staining Beyond Botany
The staining applications of ruthenium red have quietly expanded well beyond the plant-cell-wall work where it began. In clinical pathology, the dye can highlight proteoglycans and glycosaminoglycans in animal tissues, not just pectin in plants, because all of these molecules share the same property of carrying dense negative charges. Cartilage, connective tissue matrices, and kidney basement membranes have all been stained with ruthenium red in electron microscopy studies to reveal structural details invisible with conventional heavy-metal stains.
The reagent initially gained traction among botanists as a semispecific stain for pectic substances, but over the decades it was embraced by investigators across microbiology and the animal sciences as a general-purpose stain for anionic glycosylated polymers.22PubMed. Ruthenium red and the bacterial glycocalyx The key development was a reliable preparation and fixation method that preserved the dye’s binding during the harsh processing steps of electron microscopy, where tissues are dehydrated, embedded in resin, and sliced into ultrathin sections. Without careful fixation, the stain washes out and the negatively charged structures collapse. Getting that protocol right opened up the bacterial glycocalyx, biofilm matrices, and extracellular coats of protozoa to detailed ultrastructural visualization for the first time.
Today, ruthenium red occupies an unusual niche: it is simultaneously one of the oldest staining reagents still in routine use and one of the most broadly applied pharmacological tools for calcium-channel work. Few chemical compounds span that range. Its limitations are real and well-documented, but its utility keeps it on the shelf in labs around the world, from plant biology to cardiac physiology to neuroscience.